Pa-Thai Yenchitsomanus Selected Research

mangostin

1/2022	Alpha-mangostin inhibits viral replication and suppresses nuclear factor kappa B (NF-κB)-mediated inflammation in dengue virus infection.
6/2021	Alpha-mangostin inhibits dengue virus production and pro-inflammatory cytokine/chemokine expression in dendritic cells.
1/2017	Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pa-Thai Yenchitsomanus Research Topics

Disease

37	Neoplasms (Cancer) 05/2024 - 10/2017
28	Infections 01/2024 - 05/2005
15	Cholangiocarcinoma 05/2024 - 10/2017
12	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2023 - 01/2003
10	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2018
8	Dengue (Dengue Fever) 01/2024 - 05/2005
6	Cytokine Release Syndrome 01/2022 - 06/2012
5	Severe Dengue 01/2022 - 05/2005
4	Multiple Myeloma 04/2024 - 04/2022
4	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2011
4	Triple Negative Breast Neoplasms 10/2023 - 12/2020
4	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 01/2017
4	autosomal recessive distal Renal tubular acidosis 10/2022 - 01/2003
3	Hemolytic Anemia 01/2023 - 06/2007
3	Insulinoma 01/2023 - 01/2014
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2019
3	Virus Diseases (Viral Diseases) 11/2021 - 04/2006
3	Kidney Calculi (Kidney Stone) 07/2018 - 01/2012
3	Thrombocytopenia (Thrombopenia) 01/2017 - 08/2014
3	Acidosis 09/2012 - 04/2004
2	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 01/2021
2	Inflammation (Inflammations) 01/2024 - 01/2022
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2023 - 01/2023
2	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 02/2021
2	Hyperglycemia 01/2021 - 01/2021
2	Kidney Diseases (Kidney Disease) 10/2010 - 02/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2023
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2023
1	Lung Neoplasms (Lung Cancer) 04/2023
1	Plasmacytoma 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
14	dirhodium tetraacetate (DRTA)IBA 01/2023 - 01/2003
12	AntigensIBA 05/2024 - 10/2017
11	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2020
11	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2023 - 01/2003
11	CytokinesIBA 01/2023 - 06/2012
8	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2016
7	Peptides (Polypeptides)IBA 02/2024 - 08/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2016
5	AnionsIBA 01/2017 - 09/2004
4	RNA (Ribonucleic Acid)IBA 02/2024 - 10/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2020
4	ChemokinesIBA 01/2022 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2014
4	Messenger RNA (mRNA)IBA 12/2020 - 02/2015
3	B-Cell Maturation AntigenIBA 04/2024 - 04/2022
3	Transcription Factors (Transcription Factor)IBA 03/2024 - 08/2012
3	LigandsIBA 11/2023 - 01/2018
3	NucleolinIBA 09/2023 - 01/2022
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2021
3	NF-kappa B (NF-kB)IBA 01/2023 - 01/2020
3	mangostinIBA 01/2022 - 01/2017
3	VaccinesIBA 11/2021 - 11/2015
3	EnzymesIBA 12/2020 - 09/2008
3	Interleukin-10 (Interleukin 10)IBA 10/2020 - 01/2016
3	Viral RNAIBA 01/2020 - 02/2015
3	Insulin (Novolin)FDA Link 07/2019 - 03/2002
3	Transaminases (Aminotransferases)IBA 01/2017 - 08/2014
2	IntegrinsIBA 05/2024 - 01/2021
2	Viral ProteinsIBA 01/2024 - 04/2006
2	B7-H1 AntigenIBA 12/2023 - 01/2023
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 04/2022
2	Immune Checkpoint ProteinsIBA 11/2023 - 01/2023
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 01/2021
2	AcidsIBA 01/2023 - 01/2018
2	Monoclonal AntibodiesIBA 12/2022 - 01/2021
2	GenisteinIBA 07/2022 - 01/2022
2	Folate Receptor 1IBA 01/2022 - 02/2021
2	Gemcitabine FDA Link 01/2022 - 01/2020
2	SirtuinsIBA 11/2021 - 01/2019
2	PolymersIBA 10/2021 - 01/2017
2	cordycepinIBA 10/2021 - 05/2021
2	Viral Nonstructural ProteinsIBA 01/2021 - 01/2020
2	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2020 - 01/2018
2	Neoplasm Antigens (Tumor Antigens)IBA 11/2019 - 10/2017
2	MorpholinosIBA 01/2019 - 04/2018
2	3' Untranslated Regions (3' UTR)IBA 01/2019 - 04/2018
2	Coat Protein Complex I (COPI)IBA 01/2018 - 01/2017
2	ChloridesIBA 01/2017 - 09/2004
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2017 - 09/2004
2	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 08/2002
2	Hemoglobins (Hemoglobin)IBA 07/2009 - 06/2007
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2024
1	Surface Antigens (Surface Antigen)IBA 02/2024
1	ethyl 4-methoxycinnamateIBA 01/2024
1	HLA-A Antigens (HLA-A)IBA 12/2023
1	Granzymes (Granzyme)IBA 12/2023
1	PhytochemicalsIBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 04/2023
1	Oncogene Proteins (Oncogene Protein)IBA 04/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2023
1	Polysaccharides (Glycans)IBA 04/2023
1	WT1 ProteinsIBA 01/2023
1	Caspase 8 (Caspase-8)IBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Caspase 9IBA 01/2023

Therapy/Procedure

17	Therapeutics 05/2024 - 06/2007
11	Immunotherapy 12/2023 - 10/2017
5	Drug Therapy (Chemotherapy) 07/2022 - 01/2019